Biotechnology VALUE FUND L P, 10% Owner at Xenon Pharmaceuticals Inc. (XENE), bought 162,426 shares at $3.04 ($494K) on 2017-06-27, disclosed to the SEC on 2017-06-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.04 | 8,496 | $26K | 5.2% |
| 2 | $3.04 | 30,170 | $92K | 18.6% |
| 3 | $3.04 | 30,170 | $92K | 18.6% |
| 4 | $3.04 | 46,795 | $142K | 28.8% |
| 5 | $3.04 | 46,795 | $142K | 28.8% |
| Total | $3.04 avg | 162,426 |
| $494K |
| 100% |
| Filing → |
| KYMR | BUY | 2022-05-24 | $141K | — | Filing → |
| OLMA | BUY | 2021-12-02 | $13.9M | — | Filing → |
| KYMR | BUY | 2021-07-06 | $25.6M | — | Filing → |